CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...
Phase 3
Los Angeles, California, United States and 108 other locations
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...
Phase 3
Los Angeles, California, United States and 123 other locations
This is a Phase II multi-center, double-blind, placebo-controlled, randomized study in Patients with moderate to severe lung injury due to COVID...
Phase 2
Santa Monica, California, United States and 1 other location
COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a dysregulated...
Phase 2, Phase 3
Fullerton, California, United States and 19 other locations
stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...
West Hollywood, California, United States and 47 other locations
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...
Phase 3
Culver City, California, United States and 17 other locations
The primary objective of this study is to evaluate the safety and tolerability of intravenous (IV) IMM-BCP-01 in subjects with mild to moderate COVID...
Phase 1
Long Beach, California, United States of America and 2 other locations
A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...
Phase 2, Phase 3
Newport Beach, California, United States of America and 28 other locations
The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...
Phase 2
Tustin, California, United States and 29 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Los Angeles, California, United States and 217 other locations
Clinical trials
Research sites
Resources
Legal